Sicard; Helene

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sicard; Helene.The latest application filed is for "treatment with anti-kir3dl2 agents".

Company Profile

4.5.9

Sicard; Helene - Marseilles FR
SICARD; HELENE - MARSEILLE FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma Grant 11,078,275 - Bonnafous , et al. August 3, 2	2021-08-03
Treatment With Anti-kir3dl2 Agents App 20210087270 - PATUREL; CARINE ; et al.	2021-03-25
KIR3DL2 binding agents Grant 10,577,419 - Gauthier , et al.	2020-03-03
Treatment With Anti-kir3dl2 Agents App 20190248895 - PATUREL; CARINE ; et al.	2019-08-15
Treatment of peripheral T cell lymphoma Grant 10,344,087 - Bonnafous , et al. July 9, 2	2019-07-09
Compound That Specifically Binds To Kir3dl2 For Use In The Treatment Of Peripheral T Cell Lymphoma App 20190127463 - BONNAFOUS; CECILE ; et al.	2019-05-02
KIR3DL2 binding agents Grant 10,246,510 - Gauthier , et al.	2019-04-02
Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma Grant 10,174,112 - Bonnafous , et al. J	2019-01-08
Compound That Specifically Binds To Kir3dl2 For Use In The Treatment Of Peripheral T Cell Lymphoma App 20170298132 - BONNAFOUS; CECILE ; et al.	2017-10-19
Treatment Of Peripheral T Cell Lymphoma App 20150376274 - BONNAFOUS; CECILE ; et al.	2015-12-31
Compositions and Methods for Regulating an Immune Response in a Subject App 20100254940 - Romagne; Francois ; et al.	2010-10-07
Methods of Using Phosphoantigens Together with Interleukin-2 for the Treatment of Cancer App 20100189681 - Sicard; Helene	2010-07-29
Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using Gamma Delta T Cell Activators App 20090304688 - Fournie; Jean-Jacques ; et al.	2009-12-10
Compositions and methods for regulating an immune response in a subject App 20060194755 - Romagne; Francois ; et al.	2006-08-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.